Home Cart Sign in  
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 121588-79-2 Chemical Structure| 121588-79-2

Structure of 121588-79-2

Chemical Structure| 121588-79-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of [ 121588-79-2 ]

CAS No. :121588-79-2
Formula : C7H15NO
M.W : 129.20
SMILES Code : N[C@H]1CC[C@H](OC)CC1
MDL No. :MFCD20278175
InChI Key :SDMXLAZIFYYECU-UHFFFAOYSA-N
Pubchem ID :409910

Safety of [ 121588-79-2 ]

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H226-H302-H335-H314
Precautionary Statements:P210-P240-P241-P242-P243-P260-P264-P270-P271-P280-P301+P330+P331-P303+P361+P353-P304+P340-P305+P351+P338-P310-P363-P370+P378-P403+P233-P403+P235-P405-P501
Class:3(8)
UN#:2733
Packing Group:

Computational Chemistry of [ 121588-79-2 ] Show Less

Physicochemical Properties

Num. heavy atoms 9
Num. arom. heavy atoms 0
Fraction Csp3 1.0
Num. rotatable bonds 1
Num. H-bond acceptors 2.0
Num. H-bond donors 1.0
Molar Refractivity 37.44
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

35.25 Ų

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

1.93
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

0.47
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

0.9
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

0.57
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

0.81
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

0.94

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-0.87
Solubility 17.4 mg/ml ; 0.135 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Very soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

-0.78
Solubility 21.5 mg/ml ; 0.166 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Very soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-0.82
Solubility 19.7 mg/ml ; 0.153 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

High
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

Yes
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

No
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

No
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

No
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

No
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

No
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-6.75 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

1.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.55

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

0.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<1.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

2.21

Application In Synthesis of [ 121588-79-2 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 121588-79-2 ]

[ 121588-79-2 ] Synthesis Path-Downstream   1~35

  • 2
  • [ 330785-84-7 ]
  • [ 121588-79-2 ]
  • C25H34ClN5O4 [ No CAS ]
  • 3
  • [ 121588-79-2 ]
  • [ 5334-40-7 ]
  • N-((1r,4r)-4-methoxycyclohexyl)-4-nitro-1H-pyrazole-3-carboxamide [ No CAS ]
  • 4
  • [ 121588-79-2 ]
  • 4-(2-fluorobenzamido)-N-(4-methoxycyclohexyl)-1H-pyrazole-3-carboxamide [ No CAS ]
  • 5
  • [ 121588-79-2 ]
  • N-(4-methoxycyclohexyl)-4-(2-(trifluoromethyl)benzamido)-1H-pyrazole-3-carboxamide [ No CAS ]
  • 6
  • [ 121588-79-2 ]
  • 4-(2-ethylbenzamido)-N-(4-methoxycyclohexyl)-1H-pyrazole-3-carboxamide [ No CAS ]
  • 7
  • [ 121588-79-2 ]
  • 4-(2-methoxybenzamido)-N-(4-methoxycyclohexyl)-1H-pyrazole-3-carboxamide [ No CAS ]
  • 8
  • [ 121588-79-2 ]
  • N-(4-methoxycyclohexyl)-4-(2-(phenylamino)benzamido)-1H-pyrazole-3-carboxamide [ No CAS ]
  • 9
  • [ 121588-79-2 ]
  • 4-(2-((2,3-dimethylphenyl)amino)benzamido)-N-(4-methoxycyclohexyl)-1H-pyrazole-3-carboxamide [ No CAS ]
  • 10
  • [ 121588-79-2 ]
  • 4-(2,6-dimethoxybenzamido)-N-(4-methoxycyclohexyl)-1H-pyrazole-3-carboxamide [ No CAS ]
  • 11
  • [ 121588-79-2 ]
  • N-(4-methoxycyclohexyl)-4-(2,4,6-trimethoxybenzamido)-1H-pyrazole-3-carboxamide [ No CAS ]
  • 12
  • [ 121588-79-2 ]
  • 4-(2,4-difluorobenzamido)-N-(4-methoxycyclohexyl)-1H-pyrazole-3-carboxamide [ No CAS ]
  • 13
  • [ 121588-79-2 ]
  • 4-(3,5-difluorobenzamido)-N-(4-methoxycyclohexyl)-1H-pyrazole-3-carboxamide [ No CAS ]
  • 14
  • [ 121588-79-2 ]
  • 4-(3,5-dichlorobenzamido)-N-(4-methoxycyclohexyl)-1H-pyrazole-3-carboxamide [ No CAS ]
  • 15
  • [ 121588-79-2 ]
  • 4-(4-(difluoromethoxy)benzamido)-N-(4-methoxycyclohexyl)-1H-pyrazole-3-carboxamide [ No CAS ]
  • 16
  • [ 121588-79-2 ]
  • N-(4-methoxycyclohexyl)-4-(4-(pyrrolidin-1-yl)benzamido)-1H-pyrazole-3-carboxamide [ No CAS ]
  • 17
  • [ 121588-79-2 ]
  • N-(4-methoxycyclohexyl)-4-(4-(4-methylpiperazin-1-yl)benzamido)-1H-pyrazole-3-carboxamide [ No CAS ]
  • 18
  • [ 121588-79-2 ]
  • 4-(benzofuran-2-carboxamido)-N-(4-methoxycyclohexyl)-1H-pyrazole-3-carboxamide [ No CAS ]
  • 19
  • [ 121588-79-2 ]
  • N-(3-((4-methoxycyclohexyl)carbamoyl)-1H-pyrazol-4-yl)pyrazolo[1,5-a]pyridine-2-carboxamide [ No CAS ]
  • 20
  • [ 121588-79-2 ]
  • N-(3-((4-methoxycyclohexyl)carbamoyl)-1H-pyrazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide [ No CAS ]
  • 21
  • [ 121588-79-2 ]
  • N-(3-((4-methoxycyclohexyl)carbamoyl)-1H-pyrazol-4-yl)-2-methylimidazo[1,2-a]pyridine-3-carboxamide [ No CAS ]
  • 22
  • [ 121588-79-2 ]
  • N-(4-methoxycyclohexyl)-4-(5-phenylfuran-2-carboxamido)-1H-pyrazole-3-carboxamide [ No CAS ]
  • 23
  • [ 121588-79-2 ]
  • N-(3-((4-methoxycyclohexyl)carbamoyl)-1H-pyrazol-4-yl)-5-phenyloxazole-4-carboxamide [ No CAS ]
  • 24
  • [ 121588-79-2 ]
  • 4-amino-N-(4-methoxycyclohexyl)-1H-pyrazole-3-carboxamide [ No CAS ]
  • 25
  • [ 121588-79-2 ]
  • 4-(4,4-difluorocyclohexanecarboxamido)-N-(4-methoxycyclohexyl)-1H-pyrazole-3-carboxamide [ No CAS ]
  • 26
  • [ 121588-79-2 ]
  • N-(4-methoxycyclohexyl)-4-(tetrahydro-2H-pyran-4-carboxamido)-1H-pyrazole-3-carboxamide [ No CAS ]
  • 27
  • [ 121588-79-2 ]
  • 4-(2-(2-fluorophenyl)acetamido)-N-(4-methoxycyclohexyl)-1H-pyrazole-3-carboxamide [ No CAS ]
  • 28
  • [ 121588-79-2 ]
  • N-(4-methoxycyclohexyl)-4-(2-(2-methoxyphenyl)acetamido)-1H-pyrazole-3-carboxamide [ No CAS ]
  • 29
  • [ 121588-79-2 ]
  • 4-(2-(2,6-dichlorophenyl)acetamido)-N-(4-methoxycyclohexyl)-1H-pyrazole-3-carboxamide [ No CAS ]
  • 30
  • [ 121588-79-2 ]
  • 4-benzamido-N-(4-methoxycyclohexyl)-1H-pyrazole-3-carboxamide [ No CAS ]
  • 31
  • [ 121588-79-2 ]
  • [ 1160105-56-5 ]
  • 4-(3-isopropyl-1H-pyrazol-4-yl)-N-(trans-4-methoxycyclohexyl)pyrimidin-2-amine [ No CAS ]
  • 32
  • [ 121588-79-2 ]
  • [ 1228013-60-2 ]
  • ethyl 2-(5-bromo-3-(trans-4-methoxycyclohexylamino)pyrazin-2-ylamino)acetate [ No CAS ]
  • 33
  • [ 121588-79-2 ]
  • [ 1228013-85-1 ]
  • 6-bromo-4-((trans)-4-methoxycyclohexyl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1H)-one [ No CAS ]
  • 34
  • [ 121588-79-2 ]
  • (R)-2-(6-(2,5-dichloropyrimidin-4-yl)-1-oxoisoindolin-2-yl)-N-((S)-2-hydroxy-1-(3-methoxyphenyl)ethyl)propanamide [ No CAS ]
  • (2R)-2-[6-(5-chloro-2-[trans-4-methoxycyclohexyl]amino}pyrimidin-4-yl)-1-oxo-2,3-dihydro-1H-isoindol-2-yl]-N-[(1S)-2-hydroxy-1-(3-methoxyphenyl)ethyl]propanamide [ No CAS ]
YieldReaction ConditionsOperation in experiment
50.1% With N-ethyl-N,N-diisopropylamine; In 1,4-dioxane; ethanol; at 80℃;Inert atmosphere; Example 625: (2R)-2-[6-(5-chloro-2-[trans-4-methoxycyclohexyl]amino}pyrimidin-4-yl)-1 - oxo-2,3-dihydro-1 H-isoindol-2-y l]-N-[(1 S)-2-hydroxy-1 -(3- methoxyphenyl)ethyl]propanamide (3479) (3480) A mixture of (R)-2-(6-(2,5-dichloropyrimidin-4-yl)-1-oxoisoindolin-2-yl)-N-((S)-2-hydroxy-1-(3- methoxyphenyl)ethyl)propanamide (Preparation 352, 0.1 g, 0.199 mmol), DIPEA (0.070 ml, 0.399 mmol) and trans 4-methoxycyclohexanamine (0.039 g, 0.299 mmol) (0.024 ml, 0.232 mmol) in 1 :1 EtOH:dioxane (1 mL) was heated at 80C under nitrogen overnight. The mixture was allowed to cool to room temperature and was concentrated under vacuum. The residue was dissolved in EtOAc and transferred into a separating funnel. 1 N HCI was added and the crude product was extracted with EtOAc. The combined organic extracts were washed with NaHC03, brine, dried (MgS04) and absorbed on silica. The crude product was purified by chromatography on the Companion (12 g column, 0- 5 % MeOH in DCM) to afford the title compound (0.06g, 050.1 %) as a white solid after trituration and evaporation from Et.20. 1 H NMR (DMSO-d6) delta: 8.56 (d, 1 H), 8.44 (s (br), 1 H), 8.07 - 8.01 (m, 1 H), 7.97 (d, 1 H), 7.75 (d, 1 H), 7.52 (s (br), 1 H), 7.28 - 7.19 (m, 1 H), 6.93 - 6.85 (m, 2H), 6.83 - 6.76 (m, 1 H), 5.06 - 4.96 (m, 1 H), 4.89 (t, 1 H), 4.85 - 4.80 (m, 1 H), 4.77 (d, 1 H), 4.60 (d, 1 H), 3.75 (s, 3H), 3.73 - 3.63 (m, 1 H), 3.57 - 3.52 (m, 2H), 3.23 (s, 3H), 3.16 - 3.06 (m, 1 H), 2.05 - 1.91 (m, 4H), 1.45 (d, 3H), 1.39 - 1.13 (m, 4H). LCMS: [M+H]+ = 594.
  • 35
  • [ 121588-79-2 ]
  • (S)-2-(3-(2,5-dichloropyrimidin-4-yl)-5-oxo-5,7-dihydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-N-(2-hydroxy-1-(m-tolyl)ethyl)acetamide [ No CAS ]
  • 2-[3-(5-chloro-2-[trans-4-methoxycyclohexyl]amino}pyrimidin-4-yl)-5-oxo-5H,6H,7H-pyrrolo[3,4-b]pyridin-6-yl]-N-[(1S)-2-hydroxy-1-(3-methylphenyl)ethyl]acetamide [ No CAS ]
YieldReaction ConditionsOperation in experiment
52 mg With N-ethyl-N,N-diisopropylamine; In 1,4-dioxane; at 90℃; for 16h;Inert atmosphere; Example 660: 2-[3-(5-chloro-2-[trans-4-methoxycyclohexyl]amino}pyrimidin-4-yl)-5-oxo- 5H,6H,7H-pyrrolo[3,4-b]pyridin-6-yl]-N-[(1S)-2-hydroxy-1-(3-methylphenyl)ethyl]acetamide (3567) DIPEA (59.9 muIota, 0.343 mmol) was added to a stirred solution of (S)-2-(3-(2,5-dichloropyrimidin- 4-yl)-5-oxo-5H-pyrrolo[3^-b]pyridin-6(7H)-yl)-N-(2-hydroxy-1-(m-tolyl)ethyl)acetarnide (80 mg, 0.137 mmol) and (1 r,4r)-4-methoxycyclohexanamine (26.6 mg, 0.206 mmol) in dioxane (1 mL) under nitrogen. The mixture was heated to 90 C and stirred for 16 h. The mixture was allowed to cool to room temperature and was diluted with EtOAc (20 mL) and water (20 mL). The phases were separated and the aqueous layer was extracted with EtOAc (2 x 20 mL). The combined organic extracts were washed with brine (60 mL), dried (MgS0 ) and concentrated. The crude product was purified by chromatography (SiO2, 24 g column, 0-10% MeOH in DCM) to afford a beige solid. The product was loaded onto a column packed with SCX (0.5 g) in MeOH. The column was washed with MeOH and the product eluted with 0.7 M ammonia in MeOH. The resulting mixture was concentrated in vacuo to afford the title compound (52 mg, 66.4 %) as a beige solid. 1 H NMR (DMSO-d6, 400 MHz) delta 9.09 (1 H, s), 8.54 (1 H, d), 8.48 (1 H, s (br)), 8.40 (1 H, d), 7.62 (1 H, s (br)), 7.21 (1 H, t), 7.15 - 7.08 (2H, m), 7.07 - 7.03 (1 H, m), 4.91 (1 H, t), 4.88 - 4.80 (1 H, m), 4.64 (2H, s), 4.34 (1 H, d), 4.29 (1 H, d), 3.77 - 3.62 (1 H, m), 3.61 - 3.50 (2H, m), 3.22 (3H, s), 3.17 - 3.05 (1 H, m), 2.29 (3H, s), 2.10 - 1.84 (4H, m), 1.41 - 1.24 (2H, m), 1.24 - 1.11 (2H, m). LCMS: [M+H]+ = 565.
 

Historical Records

Technical Information

Categories

Similar Product of
[ 121588-79-2 ]

Chemical Structure| 61367-41-7

A312730 [61367-41-7]

trans-4-Methoxycyclohexanamine hydrochloride

Reason: Free-salt

Related Functional Groups of
[ 121588-79-2 ]

Aliphatic Cyclic Hydrocarbons

Chemical Structure| 175867-01-3

A178536 [175867-01-3]

trans-4-(2-Methoxyethoxy)cyclohexanamine

Similarity: 0.92

Chemical Structure| 1174044-78-0

A158262 [1174044-78-0]

4-(tert-Butoxy)cyclohexanamine hydrochloride

Similarity: 0.85

Chemical Structure| 6850-65-3

A283033 [6850-65-3]

4-Aminocyclohexan-1-ol(only contains trans)

Similarity: 0.83

Chemical Structure| 27489-62-9

A775896 [27489-62-9]

trans-4-Aminocyclohexanol

Similarity: 0.83

Chemical Structure| 1408074-49-6

A315906 [1408074-49-6]

trans-3-Methoxycyclobutanamine hydrochloride

Similarity: 0.81

Ethers

Chemical Structure| 175867-01-3

A178536 [175867-01-3]

trans-4-(2-Methoxyethoxy)cyclohexanamine

Similarity: 0.92

Chemical Structure| 1174044-78-0

A158262 [1174044-78-0]

4-(tert-Butoxy)cyclohexanamine hydrochloride

Similarity: 0.85

Chemical Structure| 1408074-49-6

A315906 [1408074-49-6]

trans-3-Methoxycyclobutanamine hydrochloride

Similarity: 0.81

Chemical Structure| 18068-06-9

A134117 [18068-06-9]

4-Methoxycyclohexanol

Similarity: 0.70

Chemical Structure| 22188-03-0

A302708 [22188-03-0]

trans-4-Methoxycyclohexanol

Similarity: 0.70

Amines

Chemical Structure| 175867-01-3

A178536 [175867-01-3]

trans-4-(2-Methoxyethoxy)cyclohexanamine

Similarity: 0.92

Chemical Structure| 1174044-78-0

A158262 [1174044-78-0]

4-(tert-Butoxy)cyclohexanamine hydrochloride

Similarity: 0.85

Chemical Structure| 6850-65-3

A283033 [6850-65-3]

4-Aminocyclohexan-1-ol(only contains trans)

Similarity: 0.83

Chemical Structure| 27489-62-9

A775896 [27489-62-9]

trans-4-Aminocyclohexanol

Similarity: 0.83

Chemical Structure| 1408074-49-6

A315906 [1408074-49-6]

trans-3-Methoxycyclobutanamine hydrochloride

Similarity: 0.81